软胶囊市场按材料、应用和地区划分（2026-2032 年）

软胶囊市场评估（2026-2032）

消费者健康意识的不断提升推动了软胶囊的普及。药物配方的进步也提升了其对新型治疗方法的吸引力，推动其市场规模在2024年突破38.2亿美元，到2032年估值将达到约58.4亿美元。

除此之外，自然疗法的趋势正在刺激软胶囊的采用，软胶囊通常具有更高的生物利用度，从而更有效地输送营养，因此该市场在 2026 年至 2032 年期间的复合年增长率将达到 5.46%。

软胶囊市场定义/概述

软胶囊是一种将液体、油类或活性成分封装在明胶基壳中的给药系统。这种独特的设计使其易于吞嚥并快速溶解，从而实现胶囊内物质的有效吸收。软胶囊有多种尺寸，可与多种成分配製，包括维生素、草药萃取物和药物。

软胶囊的应用范围广泛，涵盖製药、营养保健品和化妆品行业。在製药领域，它们用于递送需要精准剂量和快速生物利用度的药物。在营养保健品领域，软胶囊作为膳食补充品广受欢迎，为消费者提供获取日常生活所需营养的便利途径。此外，软胶囊也用于化妆品中，用于包覆油脂和活性成分，从而提高产品的稳定性和功效。

对膳食补充剂和营养食品日益增长的需求将如何促进软胶囊的采用？

膳食补充剂和营养食品需求的不断增长是软胶囊市场的主要驱动力。根据美国食品药物管理局) 的数据，约 75% 的美国服用膳食补充剂，其中许多人喜欢软胶囊，因为它易于吞嚥且生物利用度更高。这一趋势推动了软胶囊技术的产量成长和创新。 2023 年 7 月，领先的软胶囊製造商 Catalent 宣布扩大其在义大利的软胶囊产能，以满足全球日益增长的需求，尤其是膳食补充剂的需求。

全球人口老化及其引发的慢性病发病率上升正在推动製药业的成长，从而刺激软胶囊市场的发展。根据世界卫生组织（WHO）的报告，2015年至2050年期间，全球60岁及以上人口的比例将几乎翻一番，从12%增加到22%。这种人口结构变化促使製药公司开发更容易服用的给药方式。 2023年8月，仙乐製药推出了一项新的植物来源软胶囊技术，以满足老年消费者对素食和纯素药物日益增长的需求。

消费者对天然和有机产品的日益增长的偏好推动了素食软胶囊的创新。美国农业部报告称，2020年有机食品和非食品产品的销售额将达到6,19亿美元，显示天然替代品市场蓬勃发展。这一趋势也延伸到了製药和营养保健品产业，软胶囊製造商正在努力开发新的配方。 2023年9月，龙沙旗下Capsugel公司推出了一系列以木薯淀粉为基础的素食软胶囊，以满足软胶囊市场对洁净标示和无过敏原产品日益增长的需求。

软胶囊的稳定性和保存期限问题是否会限制其使用？

软胶囊市场正面临诸多限制因素，可能阻碍其成长。其中一项关键挑战是软胶囊生产成本高。生产所需的专用设备和材料导致价格上涨，中小企业和新参与企业难以负担。

另一个限制因素是潜在的稳定性和储存问题。某些活性成分在软胶囊製剂中可能无法保持稳定，这限制了能够以软胶囊製剂有效递送的产品类型。这种担忧可能会促使製造商寻求能够为敏感化合物提供更高稳定性的替代递送系统。

监管障碍也给软胶囊市场带来了挑战。膳食补充剂和药品的核准流程可能漫长而复杂，尤其是在监管严格的地区。这可能会减缓新软胶囊产品的上市速度，并阻碍企业对这种给药方式的投资。

目录

第一章 引言

• 市场定义
• 细分市场
• 分析方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章 软胶囊市场（依材料）

• 明胶
• 非明胶

第五章软胶囊市场应用

• 製药
• 营养补充品
• 化妆品

第六章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第七章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• 感染疾病 -19对市场的影响

第八章 竞争态势

• 主要企业
• 市场占有率分析

第九章 公司简介

• Capsugel（Lonza）
• Aenova Group
• EuroCaps
• Catalent
• Soft Gel Technologies, Inc.
• Herbalife
• C3S
• Fuisz Pharma
• Amgen
• Pfizer
• GlaxoSmithKline
• Nature's Way
• DSM Nutritional Products
• Bausch Health
• Pharmavite LLC
• Shionogi
• NBTY
• Tishcon Corp
• Omega Protein Corporation
• JRS Pharma

第十章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十一章 附录

• 简称列表
• 来源和参考文献

Softgel Capsules Market Valuation - 2026-2032

Increasing health consciousness among consumers is propelling the adoption of softgel capsules. Advancements in drug formulations enhance the appeal of softgel capsules for new therapies and are driving the market size to surpass USD 3.82 Billion in 2024 to reach a valuation of around USD 5.84 Billion by 2032.

In addition to this, the trend toward natural remedies is spurring up the adoption of softgel capsules. Softgel capsules often offer improved bioavailability, leading to more effective nutrient delivery is enabling the market to grow at a CAGR of 5.46% from 2026 to 2032.

Softgel Capsules Market: Definition/ Overview

Softgel capsules are a form of dosage delivery system that encapsulates liquids, oils, or active ingredients within a gelatin-based shell. This unique design allows for easy swallowing and quick dissolution, enabling efficient absorption of the encapsulated substances. Softgels are available in various sizes and can be formulated to contain a wide range of ingredients, including vitamins, herbal extracts, and pharmaceuticals.

The applications of softgel capsules are diverse, spanning the pharmaceutical, nutraceutical, and cosmetic industries. In pharmaceuticals, they are used to deliver medications that require precise dosing and rapid bioavailability. In the nutraceutical sector, softgels are popular for dietary supplements, offering consumers an easy way to incorporate essential nutrients into their daily routines. Additionally, softgels are used in cosmetics for encapsulating oils and active ingredients, enhancing product stability and effectiveness.

How will Rising Demand for Nutraceuticals and Dietary Supplements Increase Adoption of Softgel Capsules?

The rising demand for nutraceuticals and dietary supplements has been a significant driver of the softgel capsules market. According to the U.S. Food and Drug Administration, about 75% of Americans take dietary supplements, with many preferring softgel capsules for their ease of swallowing and improved bioavailability. This trend has led to increased production and innovation in softgel technology. In July 2023, Catalent, a leading softgel manufacturer, announced the expansion of its softgel manufacturing capacity in Italy to meet growing global demand, particularly for nutraceutical products.

An aging global population and the associated increase in chronic diseases have fueled the growth of the pharmaceutical sector, consequently boosting the softgel capsules market. The World Health Organization reported that between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. This demographic shift has spurred pharmaceutical companies to develop more easily consumable drug delivery forms. In August 2023, Sirio Pharma unveiled a new plant-based softgel technology, catering to the growing demand for vegetarian and vegan-friendly medication options among older consumers.

The increasing consumer preference for natural and organic products has driven innovation in plant-based softgel capsules. The U.S. Department of Agriculture reported that sales of organic food and non-food products reached USD 61.9 Billion in 2020, indicating a strong market for natural alternatives. This trend has extended to the pharmaceutical and nutraceutical industries, prompting softgel manufacturers to develop new formulations. In September 2023, Capsugel, a Lonza company, launched a new line of plant-based softgel capsules made from tapioca starch, addressing the growing demand for clean-label and allergen-free products in the softgel market.

Will Stability and Shelf-Life Issues of Softgel Capsules Restrain Its Application?

The softgel capsules market faces several restraints that may impede its growth. One significant challenge is the high production costs associated with manufacturing softgel capsules. The specialized equipment and materials required for their production can lead to increased prices, making it less accessible for smaller companies and new entrants in the market.

Another restraint is the potential for stability and shelf-life issues. Some active ingredients may not remain stable within softgel formulations, which can limit the types of products that can be effectively delivered in this form. This concern may lead manufacturers to seek alternative delivery systems that offer better stability for sensitive compounds.

Regulatory hurdles also pose challenges to the softgel market. The approval processes for dietary supplements and pharmaceuticals can be lengthy and complex, particularly in regions with stringent regulations. This can slow down the introduction of new softgel products and deter companies from investing in this delivery format.

Category-Wise Acumens

Will Gelatin Segment Hold Major Share in Softgel Capsules Market?

Gelatin continues to dominate the softgel capsules market due to its unique properties and widespread acceptance in the pharmaceutical industry. According to the U.S. Food and Drug Administration's Inactive Ingredient Database, gelatin is listed in over 1,000 approved drug products as of 2023, highlighting its prevalence in pharmaceutical formulations. This widespread use is attributed to gelatin's excellent oxygen barrier properties, compatibility with a wide range of fill materials, and cost-effectiveness. In July 2023, Rousselot, a leading gelatin manufacturer, announced the launch of a new pharmaceutical-grade gelatin specifically designed for softgel applications, promising enhanced stability and performance.

The superior dissolution profile of gelatin-based softgels contributes significantly to their dominance in the market. The European Medicines Agency reported in 2022 that over 60% of approved oral drug products in the EU used gelatin as a primary excipient, with softgel capsules representing a substantial portion. This preference is driven by gelatin's ability to dissolve rapidly at body temperature, ensuring quick release of active ingredients. Recognizing this advantage, Catalent Pharma Solutions introduced a new gelatin-based technology in August 2023 that allows for controlled release of drugs from softgel capsules, expanding the application of gelatin in advanced drug delivery systems.

Which Factors Enhance the Use of Softgel Capsules in Nutraceutical Sector?

The nutraceutical sector has emerged as a dominant force in the softgel capsules market, driven by increasing consumer focus on preventive healthcare and wellness. According to the U.S. National Institutes of Health, over 170 million Americans take dietary supplements regularly, with softgel capsules being a preferred delivery form for many nutraceutical products. This widespread adoption has led to significant market growth and innovation. In August 2023, Nature's Bounty, a leading nutraceutical company, introduced a new line of softgel supplements featuring enhanced absorption technology, catering to the growing demand for more effective nutraceutical products.

The versatility of softgel capsules in encapsulating a wide range of nutraceutical ingredients has contributed to their popularity in this sector. The European Food Safety Authority reported in 2022 that softgel capsules accounted for approximately 40% of all new nutraceutical product launches in the EU. This preference is due to softgels' ability to mask unpleasant tastes and odors while providing improved bioavailability for many compounds. Capitalizing on this trend, in July 2023, Lonza announced the expansion of its softgel manufacturing capabilities, specifically targeting the growing demand for complex nutraceutical formulations.

Gain Access into Softgel Capsules Market Report Methodology

Country/Region-wise Acumens

Will Robust Pharmaceutical Industry in North America Drive Softgel Capsules Market Growth?

North America is establishing itself as the dominant region in the softgel capsules market, driven by a robust pharmaceutical industry and high consumer demand for dietary supplements. According to the U.S. Food and Drug Administration, approximately 75% of Americans take dietary supplements, with softgel capsules being a popular choice due to their ease of swallowing and improved absorption. This high consumption rate has led to significant market growth and innovation. In July 2023, Catalent, a leading contract development and manufacturing organization, announced a USD 350 Million investment to expand its softgel manufacturing capabilities in Kentucky, reinforcing North America's position in the market.

The region's dominance is further strengthened by its advanced healthcare infrastructure and stringent quality standards. The U.S. National Institutes of Health reported that in 2022, over 60% of clinical trials involving oral drug formulations utilized softgel capsules, highlighting their importance in pharmaceutical development. This prevalence has attracted substantial investment from key players. In August 2023, Sirio Pharma, a global nutraceutical contract development and manufacturing organization, opened a new R&D center in California focused on developing innovative softgel technologies for both pharmaceutical and nutraceutical applications.

Will Rising Healthcare Expenditure Enhance Adoption of Softgel Capsules in Asia Pacific?

The Asia Pacific region is experiencing rapid growth in the softgel capsules market, driven by increasing healthcare expenditure and a growing awareness of preventive healthcare. According to China's National Medical Products Administration, the number of approved softgel capsule formulations increased by 28% between 2020 and 2022, reflecting the rising demand for this delivery form. This growth has attracted significant investment from global players. In August 2023, Catalent announced the expansion of its softgel manufacturing facility in Japan, doubling its production capacity to meet the increasing regional demand for both pharmaceutical and nutraceutical softgel products.

India has emerged as a key contributor to the region's market growth, with its large pharmaceutical manufacturing base. The Indian Ministry of Commerce and Industry reported that pharmaceutical exports, including softgel capsules, grew by 18% in the fiscal year 2022-23 compared to the previous year. This growth has spurred innovation in the sector. In July 2023, ACG Group, a leading Indian pharmaceutical supplier, launched a new range of vegetarian softgel capsules made from plant-based materials, catering to the growing demand for vegetarian options in the Asian market.

Competitive Landscape

The softgel capsules market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the softgel capsules market include:

• Capsugel (Lonza)
• Aenova Group
• EuroCaps
• Catalent
• Soft Gel Technologies, Inc.
• Herbalife
• C3S
• Fuisz Pharma
• Amgen
• Pfizer
• GlaxoSmithKline
• Nature's Way
• DSM Nutritional Products
• Bausch Health
• Pharmavite LLC
• Shionogi
• NBTY
• Tishcon Corp
• Omega Protein Corporation
• JRS Pharma

Latest Developments

• In September 2023, a major manufacturer in the softgel capsules market announced the launch of a new line of plant-based softgels, catering to the growing demand for vegan and clean-label products.
• In August 2023, a leading research firm released a report forecasting a CAGR of 6.5% for the softgel capsules market through 2030, driven by increasing consumer preference for dietary supplements and pharmaceuticals.

Softgel Capsules Market, By Category

• Material:
• Gelatin
• Non-Gelatin
• Application:
• Pharmaceutical
• Nutraceuticals
• Cosmetics
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Softgel Capsules Market, By Material

• Gelatin
• Non-gelatin

5. Softgel Capsules Market, By Application

• Pharmaceuticals
• Nutraceuticals
• Cosmetics

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• Capsugel (Lonza)
• Aenova Group
• EuroCaps
• Catalent
• Soft Gel Technologies, Inc.
• Herbalife
• C3S
• Fuisz Pharma
• Amgen
• Pfizer
• GlaxoSmithKline
• Nature's Way
• DSM Nutritional Products
• Bausch Health
• Pharmavite LLC
• Shionogi
• NBTY
• Tishcon Corp
• Omega Protein Corporation
• JRS Pharma

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References